文献速递类风湿关节炎系统性红斑狼疮

类风湿关节炎与系统性红斑狼疮急性心血管事件结局:一项基于人群的研究

Outcomes of acute cardiovascular events in rheumatoid arthritis and systemic lupus erythematosus: a population-based study.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

该研究利用台湾地区全国性数据库,纳入13年间首次发生急性心肌梗死、颅内出血和缺血性卒中的成年患者,评估合并RA和SLE与院内死亡、远期死亡及不良结局的关联。结果显示,RA和SLE均与三类急性心血管事件后的院内死亡、总体死亡及部分不良结局风险升高相关。

要点

  • RA和SLE患者急性心肌梗死后院内死亡风险升高(RA OR 1.61,SLE OR 2.31)。
  • RA和SLE患者颅内出血后院内死亡风险升高(RA OR 1.61,SLE OR 3.00)。
  • SLE患者缺血性卒中后复发风险更高(HR 1.39)。

核心结论

  • RA和SLE均与急性心血管事件后的不良结局持续相关,提示需要对患者进行整合管理。

研究设计与样本

  • 在各队列中,急性心肌梗死、颅内出血和缺血性卒中队列分别有748、410和1419例患者确诊RA,256、292和622例患者确诊SLE。
  • 采用比值比(OR)评估院内死亡风险,风险比(HR)评估远期总体死亡及不良结局风险,并校正潜在混杂因素。

主要发现

  • 急性心肌梗死患者中,RA与院内死亡相关(OR 1.61,95%CI 1.33,1.95),SLE与院内死亡相关(OR 2.31,95%CI 1.62,3.28),且两者均与总体死亡相关。
  • 急性心肌梗死患者中,RA(HR 1.28,95%CI 1.18,1.38)和SLE(HR 1.46,95%CI 1.27,1.69)增加主要不良心脏事件风险。
  • 颅内出血患者中,RA与院内死亡相关(OR 1.61,95%CI 1.26,2.06),SLE与院内死亡相关(OR 3.00,95%CI 2.33,3.86),且两者均与总体死亡相关。
  • 缺血性卒中患者中,RA与院内死亡相关(OR 1.45,95%CI 1.15,1.83),SLE与院内死亡相关(OR 2.18,95%CI 1.57,3.02),且两者均与总体死亡及复发性脑血管事件相关(RA HR 1.10,95%CI 1.002,1.21;SLE HR 1.31,95%CI 1.14,1.51)。
  • SLE患者缺血性卒中复发风险更高(HR 1.39,95%CI 1.19,1.62)。

关键数值与推荐

  • 急性心肌梗死:RA院内死亡OR 1.61(95%CI 1.33,1.95),SLE OR 2.31(95%CI 1.62,3.28);RA主要不良心脏事件HR 1.28(95%CI 1.18,1.38),SLE HR 1.46(95%CI 1.27,1.69)。
  • 颅内出血:RA院内死亡OR 1.61(95%CI 1.26,2.06),SLE OR 3.00(95%CI 2.33,3.86)。
  • 缺血性卒中:RA院内死亡OR 1.45(95%CI 1.15,1.83),SLE OR 2.18(95%CI 1.57,3.02);复发性脑血管事件RA HR 1.10(95%CI 1.002,1.21),SLE HR 1.31(95%CI 1.14,1.51);SLE缺血性卒中复发HR 1.39(95%CI 1.19,1.62)。

临床怎么用

  • 对合并RA或SLE的急性心血管事件患者,应警惕院内死亡及远期不良结局风险升高。
  • SLE患者急性心血管事件后不良结局风险更高,尤其是颅内出血和缺血性卒中复发,需加强监测与二级预防。
  • 风湿免疫科与心血管科、神经科应协同管理RA和SLE患者的心血管风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Patients with RA and SLE have an excess cardiovascular risk. We aimed to evaluate outcomes of acute cardiovascular events in these patients. METHODS: Using a nationwide database of Taiwan, we identified adult patients who experienced first-time acute myocardial infarction (n = 191 008), intracranial haemorrhage (n = 169 923) and ischaemic stroke (n = 486 890) over a 13-year period. Odds ratios (ORs) of in-hospital mortality and hazard ratios (HRs) of overall mortality and adverse outcomes during long-term follow-up in relation to RA and SLE were estimated with adjustment for potential confounders. RESULTS: In each cohort, 748, 410 and 1419 patients had established RA; 256, 292 and 622 patients had SLE. Among acute myocardial infarction patients, RA and SLE were associated with in-hospital mortality (RA: OR 1.61, 95% CI 1.33, 1.95; SLE: OR 2.31, 95% CI 1.62, 3.28) and overall mortality. Additionally, RA (HR 1.28, 95% CI 1.18, 1.38) and SLE (HR 1.46, 95% CI 1.27, 1.69) increased the risk of major adverse cardiac events. After intracranial haemorrhage, patients with RA and SLE had higher risks of in-hospital mortality (RA: OR 1.61, 95% CI 1.26, 2.06; SLE: OR 3.00, 95% CI 2.33, 3.86) and overall mortality. After ischaemic stroke, RA and SLE increased in-hospital mortality (RA: OR 1.45, 95% CI 1.15, 1.83; SLE: OR 2.18, 95% CI 1.57, 3.02), overall mortality and recurrent cerebrovascular events (RA: HR 1.10, 95% CI 1.002, 1.21; SLE: HR 1.31, 95% CI 1.14, 1.51), among which ischaemic stroke (HR 1.39, 95% CI 1.19, 1.62) was more likely to recur in SLE patients. CONCLUSION: Both RA and SLE are consistently associated with adverse outcomes following acute cardiovascular events, highlighting the necessity of integrated care for affected patients.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Lai CH, Hsieh CY, Barnado A, et al. Outcomes of acute cardiovascular events in rheumatoid arthritis and systemic lupus erythematosus: a population-based study. Rheumatology (Oxford). 2020. PMID: 31600392. doi:10.1093/rheumatology/kez456

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。